長時間作用型薬物送達のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Long Acting Drug Delivery Market Insights, Forecast to 2028

• レポートコード：QY2207E09668 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の長時間作用型薬物送達の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に長時間作用型薬物送達の世界市場のxxx％を占める「装置」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の長時間作用型薬物送達の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの長時間作用型薬物送達市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの長時間作用型薬物送達市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 長時間作用型薬物送達のグローバル主要メーカーには、ViiV Healthcare、Halozyme Therapeutics、Lubrizol Life Science、Celanese Corporation、Kashiv BioSciences、4P Therapeutics、Ipsen、Midatech Pharma、Re-Vana Therapeutics、Creative Biolabsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 長時間作用型薬物送達市場は、種類と用途によって区分されます。世界の長時間作用型薬物送達市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 装置、非経口注射 【用途別セグメント】 病院、専門クリニック、臨床研究所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 長時間作用型薬物送達製品概要 - 種類別市場（装置、非経口注射） - 用途別市場（病院、専門クリニック、臨床研究所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の長時間作用型薬物送達販売量予測2017-2028 - 世界の長時間作用型薬物送達売上予測2017-2028 - 長時間作用型薬物送達の地域別販売量 - 長時間作用型薬物送達の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別長時間作用型薬物送達販売量 - 主要メーカー別長時間作用型薬物送達売上 - 主要メーカー別長時間作用型薬物送達価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（装置、非経口注射） - 長時間作用型薬物送達の種類別販売量 - 長時間作用型薬物送達の種類別売上 - 長時間作用型薬物送達の種類別価格 ・用途別市場規模（病院、専門クリニック、臨床研究所、その他） - 長時間作用型薬物送達の用途別販売量 - 長時間作用型薬物送達の用途別売上 - 長時間作用型薬物送達の用途別価格 ・北米市場 - 北米の長時間作用型薬物送達市場規模（種類別、用途別） - 主要国別の長時間作用型薬物送達市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの長時間作用型薬物送達市場規模（種類別、用途別） - 主要国別の長時間作用型薬物送達市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の長時間作用型薬物送達市場規模（種類別、用途別） - 主要国別の長時間作用型薬物送達市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の長時間作用型薬物送達市場規模（種類別、用途別） - 主要国別の長時間作用型薬物送達市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの長時間作用型薬物送達市場規模（種類別、用途別） - 主要国別の長時間作用型薬物送達市場規模（トルコ、サウジアラビア） ・企業情報 ViiV Healthcare、Halozyme Therapeutics、Lubrizol Life Science、Celanese Corporation、Kashiv BioSciences、4P Therapeutics、Ipsen、Midatech Pharma、Re-Vana Therapeutics、Creative Biolabs ・産業チェーン及び販売チャネル分析 - 長時間作用型薬物送達の産業チェーン分析 - 長時間作用型薬物送達の原材料 - 長時間作用型薬物送達の生産プロセス - 長時間作用型薬物送達の販売及びマーケティング - 長時間作用型薬物送達の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 長時間作用型薬物送達の産業動向 - 長時間作用型薬物送達のマーケットドライバー - 長時間作用型薬物送達の課題 - 長時間作用型薬物送達の阻害要因 ・主な調査結果

Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
Market Analysis and Insights: Global Long Acting Drug Delivery Market
The global Long Acting Drug Delivery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Device accounting for % of the Long Acting Drug Delivery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Long Acting Drug Delivery market size is valued at US$ million in 2021, while the North America and Europe Long Acting Drug Delivery are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Long Acting Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long Acting Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long Acting Drug Delivery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long Acting Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long Acting Drug Delivery market.
Global Long Acting Drug Delivery Scope and Market Size
Long Acting Drug Delivery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Long Acting Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Device
Parenteral Injections
Segment by Application
Hospital
Specialty Clinics
Clinical Research Institutes
Others
By Company
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Device
1.2.3 Parenteral Injections
1.3 Market by Application
1.3.1 Global Long Acting Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Clinical Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Drug Delivery Market Perspective (2017-2028)
2.2 Long Acting Drug Delivery Growth Trends by Region
2.2.1 Long Acting Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Long Acting Drug Delivery Market Dynamics
2.3.1 Long Acting Drug Delivery Industry Trends
2.3.2 Long Acting Drug Delivery Market Drivers
2.3.3 Long Acting Drug Delivery Market Challenges
2.3.4 Long Acting Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Drug Delivery Players by Revenue
3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue
3.4 Global Long Acting Drug Delivery Market Concentration Ratio
3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2021
3.5 Long Acting Drug Delivery Key Players Head office and Area Served
3.6 Key Players Long Acting Drug Delivery Product Solution and Service
3.7 Date of Enter into Long Acting Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Drug Delivery Breakdown Data by Type
4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Long Acting Drug Delivery Breakdown Data by Application
5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Long Acting Drug Delivery Market Size (2017-2028)
6.2 North America Long Acting Drug Delivery Market Size by Type
6.2.1 North America Long Acting Drug Delivery Market Size by Type (2017-2022)
6.2.2 North America Long Acting Drug Delivery Market Size by Type (2023-2028)
6.2.3 North America Long Acting Drug Delivery Market Share by Type (2017-2028)
6.3 North America Long Acting Drug Delivery Market Size by Application
6.3.1 North America Long Acting Drug Delivery Market Size by Application (2017-2022)
6.3.2 North America Long Acting Drug Delivery Market Size by Application (2023-2028)
6.3.3 North America Long Acting Drug Delivery Market Share by Application (2017-2028)
6.4 North America Long Acting Drug Delivery Market Size by Country
6.4.1 North America Long Acting Drug Delivery Market Size by Country (2017-2022)
6.4.2 North America Long Acting Drug Delivery Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Long Acting Drug Delivery Market Size (2017-2028)
7.2 Europe Long Acting Drug Delivery Market Size by Type
7.2.1 Europe Long Acting Drug Delivery Market Size by Type (2017-2022)
7.2.2 Europe Long Acting Drug Delivery Market Size by Type (2023-2028)
7.2.3 Europe Long Acting Drug Delivery Market Share by Type (2017-2028)
7.3 Europe Long Acting Drug Delivery Market Size by Application
7.3.1 Europe Long Acting Drug Delivery Market Size by Application (2017-2022)
7.3.2 Europe Long Acting Drug Delivery Market Size by Application (2023-2028)
7.3.3 Europe Long Acting Drug Delivery Market Share by Application (2017-2028)
7.4 Europe Long Acting Drug Delivery Market Size by Country
7.4.1 Europe Long Acting Drug Delivery Market Size by Country (2017-2022)
7.4.2 Europe Long Acting Drug Delivery Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Long Acting Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Long Acting Drug Delivery Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Long Acting Drug Delivery Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Long Acting Drug Delivery Market Share by Type (2017-2028)
8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Long Acting Drug Delivery Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Long Acting Drug Delivery Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Long Acting Drug Delivery Market Share by Application (2017-2028)
8.4 Asia-Pacific Long Acting Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Long Acting Drug Delivery Market Size (2017-2028)
9.2 Latin America Long Acting Drug Delivery Market Size by Type
9.2.1 Latin America Long Acting Drug Delivery Market Size by Type (2017-2022)
9.2.2 Latin America Long Acting Drug Delivery Market Size by Type (2023-2028)
9.2.3 Latin America Long Acting Drug Delivery Market Share by Type (2017-2028)
9.3 Latin America Long Acting Drug Delivery Market Size by Application
9.3.1 Latin America Long Acting Drug Delivery Market Size by Application (2017-2022)
9.3.2 Latin America Long Acting Drug Delivery Market Size by Application (2023-2028)
9.3.3 Latin America Long Acting Drug Delivery Market Share by Application (2017-2028)
9.4 Latin America Long Acting Drug Delivery Market Size by Country
9.4.1 Latin America Long Acting Drug Delivery Market Size by Country (2017-2022)
9.4.2 Latin America Long Acting Drug Delivery Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Long Acting Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Long Acting Drug Delivery Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Long Acting Drug Delivery Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Long Acting Drug Delivery Market Share by Type (2017-2028)
10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Long Acting Drug Delivery Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Long Acting Drug Delivery Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Long Acting Drug Delivery Market Share by Application (2017-2028)
10.4 Middle East & Africa Long Acting Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Details
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction
11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022)
11.1.5 ViiV Healthcare Recent Developments
11.2 Halozyme Therapeutics
11.2.1 Halozyme Therapeutics Company Details
11.2.2 Halozyme Therapeutics Business Overview
11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction
11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.2.5 Halozyme Therapeutics Recent Developments
11.3 Lubrizol Life Science
11.3.1 Lubrizol Life Science Company Details
11.3.2 Lubrizol Life Science Business Overview
11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction
11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022)
11.3.5 Lubrizol Life Science Recent Developments
11.4 Celanese Corporation
11.4.1 Celanese Corporation Company Details
11.4.2 Celanese Corporation Business Overview
11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction
11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022)
11.4.5 Celanese Corporation Recent Developments
11.5 Kashiv BioSciences
11.5.1 Kashiv BioSciences Company Details
11.5.2 Kashiv BioSciences Business Overview
11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction
11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022)
11.5.5 Kashiv BioSciences Recent Developments
11.6 4P Therapeutics
11.6.1 4P Therapeutics Company Details
11.6.2 4P Therapeutics Business Overview
11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction
11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.6.5 4P Therapeutics Recent Developments
11.7 Ipsen
11.7.1 Ipsen Company Details
11.7.2 Ipsen Business Overview
11.7.3 Ipsen Long Acting Drug Delivery Introduction
11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022)
11.7.5 Ipsen Recent Developments
11.8 Midatech Pharma
11.8.1 Midatech Pharma Company Details
11.8.2 Midatech Pharma Business Overview
11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction
11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022)
11.8.5 Midatech Pharma Recent Developments
11.9 Re-Vana Therapeutics
11.9.1 Re-Vana Therapeutics Company Details
11.9.2 Re-Vana Therapeutics Business Overview
11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction
11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.9.5 Re-Vana Therapeutics Recent Developments
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Details
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction
11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022)
11.10.5 Creative Biolabs Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Long Acting Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Device
Table 3. Key Players of Parenteral Injections
Table 4. Global Long Acting Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Long Acting Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Long Acting Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Long Acting Drug Delivery Market Share by Region (2017-2022)
Table 8. Global Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Long Acting Drug Delivery Market Share by Region (2023-2028)
Table 10. Long Acting Drug Delivery Market Trends
Table 11. Long Acting Drug Delivery Market Drivers
Table 12. Long Acting Drug Delivery Market Challenges
Table 13. Long Acting Drug Delivery Market Restraints
Table 14. Global Long Acting Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Long Acting Drug Delivery Revenue Share by Players (2017-2022)
Table 16. Global Top Long Acting Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2021)
Table 17. Ranking of Global Top Long Acting Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Long Acting Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long Acting Drug Delivery Product Solution and Service
Table 21. Date of Enter into Long Acting Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Long Acting Drug Delivery Revenue Market Share by Type (2017-2022)
Table 25. Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Long Acting Drug Delivery Revenue Market Share by Type (2023-2028)
Table 27. Global Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Long Acting Drug Delivery Revenue Share by Application (2017-2022)
Table 29. Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Long Acting Drug Delivery Revenue Share by Application (2023-2028)
Table 31. North America Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Long Acting Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Long Acting Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Long Acting Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Long Acting Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Long Acting Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Long Acting Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Long Acting Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Long Acting Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Long Acting Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Long Acting Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Long Acting Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Long Acting Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 61. ViiV Healthcare Company Details
Table 62. ViiV Healthcare Business Overview
Table 63. ViiV Healthcare Long Acting Drug Delivery Product
Table 64. ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 65. ViiV Healthcare Recent Developments
Table 66. Halozyme Therapeutics Company Details
Table 67. Halozyme Therapeutics Business Overview
Table 68. Halozyme Therapeutics Long Acting Drug Delivery Product
Table 69. Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 70. Halozyme Therapeutics Recent Developments
Table 71. Lubrizol Life Science Company Details
Table 72. Lubrizol Life Science Business Overview
Table 73. Lubrizol Life Science Long Acting Drug Delivery Product
Table 74. Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 75. Lubrizol Life Science Recent Developments
Table 76. Celanese Corporation Company Details
Table 77. Celanese Corporation Business Overview
Table 78. Celanese Corporation Long Acting Drug Delivery Product
Table 79. Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 80. Celanese Corporation Recent Developments
Table 81. Kashiv BioSciences Company Details
Table 82. Kashiv BioSciences Business Overview
Table 83. Kashiv BioSciences Long Acting Drug Delivery Product
Table 84. Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 85. Kashiv BioSciences Recent Developments
Table 86. 4P Therapeutics Company Details
Table 87. 4P Therapeutics Business Overview
Table 88. 4P Therapeutics Long Acting Drug Delivery Product
Table 89. 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 90. 4P Therapeutics Recent Developments
Table 91. Ipsen Company Details
Table 92. Ipsen Business Overview
Table 93. Ipsen Long Acting Drug Delivery Product
Table 94. Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 95. Ipsen Recent Developments
Table 96. Midatech Pharma Company Details
Table 97. Midatech Pharma Business Overview
Table 98. Midatech Pharma Long Acting Drug Delivery Product
Table 99. Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 100. Midatech Pharma Recent Developments
Table 101. Re-Vana Therapeutics Company Details
Table 102. Re-Vana Therapeutics Business Overview
Table 103. Re-Vana Therapeutics Long Acting Drug Delivery Product
Table 104. Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 105. Re-Vana Therapeutics Recent Developments
Table 106. Creative Biolabs Company Details
Table 107. Creative Biolabs Business Overview
Table 108. Creative Biolabs Long Acting Drug Delivery Product
Table 109. Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 110. Creative Biolabs Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Acting Drug Delivery Market Share by Type: 2021 VS 2028
Figure 2. Device Features
Figure 3. Parenteral Injections Features
Figure 4. Global Long Acting Drug Delivery Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Clinical Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Long Acting Drug Delivery Report Years Considered
Figure 10. Global Long Acting Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Long Acting Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Long Acting Drug Delivery Market Share by Region: 2021 VS 2028
Figure 13. Global Long Acting Drug Delivery Market Share by Players in 2021
Figure 14. Global Top Long Acting Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Long Acting Drug Delivery Revenue in 2021
Figure 16. North America Long Acting Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Long Acting Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 18. North America Long Acting Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 19. North America Long Acting Drug Delivery Market Size Share by Country (2017-2028)
Figure 20. United States Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Long Acting Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Long Acting Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 24. Europe Long Acting Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 25. Europe Long Acting Drug Delivery Market Size Share by Country (2017-2028)
Figure 26. Germany Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Long Acting Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Long Acting Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Long Acting Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Long Acting Drug Delivery Market Size Share by Region (2017-2028)
Figure 36. China Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Long Acting Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Long Acting Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Long Acting Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Long Acting Drug Delivery Market Size Share by Country (2017-2028)
Figure 46. Mexico Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Long Acting Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Long Acting Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Long Acting Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Long Acting Drug Delivery Market Size Share by Country (2017-2028)
Figure 52. Turkey Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. ViiV Healthcare Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 56. Halozyme Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 57. Lubrizol Life Science Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 58. Celanese Corporation Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 59. Kashiv BioSciences Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 60. 4P Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 61. Ipsen Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 62. Midatech Pharma Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 63. Re-Vana Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 64. Creative Biolabs Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---